Rexulti 0.5 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FBGZ1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,936
Award facts
- Contract value 100% obligated
- $23,936.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $23,936.35 delivery order to Amerisourcebergen Drug Corp on February 18, 2026, for REXULTI 0.5 mg tablet 30-count units with an ultimate completion date of February 19, 2026.
Place of performance is Conshohocken, PA. The order is issued under firm fixed-price terms with no set-aside applied.
Quick answers
Who was awarded contract SPE2DR26FBGZ1?
SPE2DR26FBGZ1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 18, 2026.
How much is contract SPE2DR26FBGZ1 worth?
The government has obligated $23,936 on SPE2DR26FBGZ1.
Is contract SPE2DR26FBGZ1 an order under another contract?
Yes. SPE2DR26FBGZ1 is a delivery order under SPE2DR25D2001, an indefinite delivery contract.
Was contract SPE2DR26FBGZ1 competed?
The extent of competition for SPE2DR26FBGZ1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award